Neoadjuvant Listeria or Daratumumab in Prostate Cancer
Conditions: Malignant Neoplasms of Male Genital Organs; Prostate Cancer Intervention: Drug: Daratumumab Sponsors: M.D. Anderson Cancer Center; Janssen-Cilag div. of Johnson&Johnson SE Not yet recruiting - verified January 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials